<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-MQNCPMK9/9631ee62-9472-43f5-868b-16b66045ea14/HTML"><dcterms:extent>26 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-MQNCPMK9/8ed87d92-8fd8-4520-8bd8-56df1595a43e/PDF"><dcterms:extent>123 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-MQNCPMK9/a4ed8103-01b3-4c60-afee-221c9c4c288a/TEXT"><dcterms:extent>24 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1929-2026"><edm:begin xml:lang="en">1929</edm:begin><edm:end xml:lang="en">2026</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:DOC-MQNCPMK9"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/urn:nbn:si:spr-a30mfzkp" /><dcterms:issued>2003</dcterms:issued><dc:creator>Milisav, Irina</dc:creator><dc:format xml:lang="sl">številka:2</dc:format><dc:format xml:lang="sl">letnik:72</dc:format><dc:format xml:lang="sl">str. 85-89</dc:format><dc:identifier>ISSN:1318-0347</dc:identifier><dc:identifier>COBISSID:15957465</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-MQNCPMK9</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Slovensko zdravniško društvo</dc:publisher><dcterms:isPartOf xml:lang="sl">Zdravniški vestnik</dcterms:isPartOf><dc:subject xml:lang="en">Gene Therapy</dc:subject><dc:subject xml:lang="en">Genetic Vectors</dc:subject><dc:subject xml:lang="sl">Genetski vektorji</dc:subject><dc:subject xml:lang="sl">gensko inženirstvo</dc:subject><dc:subject xml:lang="sl">Gensko zdravljenje</dc:subject><dc:subject xml:lang="en">Neoplasms</dc:subject><dc:subject xml:lang="sl">Novotvorbe</dc:subject><dc:subject xml:lang="en">Oligonucleotides, Antisense</dc:subject><dc:subject xml:lang="sl">Oligonukleotidi protismerni</dc:subject><dc:subject xml:lang="en">Plasmids</dc:subject><dc:subject xml:lang="sl">Plazmidi</dc:subject><dc:subject xml:lang="en">Therapy</dc:subject><dc:subject xml:lang="en">tumor</dc:subject><dc:subject xml:lang="sl">zdravljenje</dc:subject><dcterms:temporal rdf:resource="1929-2026" /><dc:title xml:lang="sl">Zdravljenje z gensko terapijo| Gene therapy|</dc:title><dc:description xml:lang="sl">Background. Gene therapy is a novel approach to treat, cure, or ultimately prevent disease by changing the expression of person's genes. Gene therapy is in its inflancy, and current gene therapy is primarily experimental, with mosthuman clinical trials only in the research stages. There were 600 studies initiated from 1990-2002, mostly in USA. Conclusions. Most of the gene therapyprotocols currently tested are for treating various cancers. This is followed by the treatment of cardiovascular diseases, genetic diseases and infectious diseases, the latter mostly to control the HIV infection. About 5 studies devoted to cancer treatment are in the third phase of the trials and may be approved for clinical use in the near future</dc:description><dc:description xml:lang="sl">Izhodišča. Genska terapija ali gensko zdravljenje je zdravstveni poseg, pri katerem se vnese genetski material (nukleinske kisline) za nadomestilo, spremembo ali utišanje izražanja genov. Z nadomestilom ali z uravnavanjem okvarjenega gena bi želeli odpraviti vzroke bolezni. Od prvih kliničnih poskusov, ki so se začeli leta 1990, do septembra 2001 je bilo po svetu začetih že približno 600 kliničnih študij, največ v ZDA. Do danes še ni bil odobren način zdravljenja, ki bi temeljil na tehnikah genske terapije, vendar je približno pet študij v zadnjih fazah kliničnih poskusov. Zaključki. Trenutno so najbolj razvite metode za zdravljenje nekaterih malignih tumorjev.Poleg tega poskušajo gensko terapijo razviti še za zdravljenje bolezni srca in žilja, genetskih bolezni in okužb z virusi, predvsem s HIV. Obugodnih rezultatih se bodo ti postopki v nekaj letih začeli uporabljati v klinični praksi</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:DOC-MQNCPMK9"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:DOC-MQNCPMK9" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:DOC-MQNCPMK9/8ed87d92-8fd8-4520-8bd8-56df1595a43e/PDF" /><edm:rights rdf:resource="http://creativecommons.org/licenses/by-nc/4.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Slovensko zdravniško društvo</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:DOC-MQNCPMK9/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:DOC-MQNCPMK9" /></ore:Aggregation></rdf:RDF>